Cipla Limited has informed the Exchange regarding a press release dated July 23, 2026, titled 'Q1 FY27 Results'
Cipla Ltd Press Release Jul 23 2026
Earlier from Cipla
- Press Release May 13 2026
- Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin HFA
- Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis
- Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation